Sonoma Pharmaceuticals
SNOA
21 hedge funds and large institutions have $1.82M invested in Sonoma Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 1 closing their positions.
500% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 1
31% more funds holding
Funds holding: 16 → 21 (+5)
28% more capital invested
Capital invested by funds: $1.42M → $1.82M (+$395K)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
Bard Associates
Chicago,
Illinois
|
+$688K |
| 2 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
+$11.7K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.39K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.26K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.13K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$78.8K |
| 2 |
Nomura Holdings
Tokyo,
Japan
|
-$31K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$26.6K |
| 4 |
Morgan Stanley
New York
|
-$12.8K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.07K |
SNOA Hedge Fund Activity: Q4 2015 in Review
21 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q4 2015, worth a combined $1.82M — up 28% from $1.42M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SNOA positions and 1 closed out — a net gain of 5 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Bard Associates, opening a new position worth an estimated $688K. The largest seller was Goldman Sachs, cutting an estimated $78.8K.
- 21 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q4 2015, up from 16 in Q3 2015.
- Funds reported $1.82M of Sonoma Pharmaceuticals stock for Q4 2015, up 28% quarter-over-quarter.
- 6 funds opened new Sonoma Pharmaceuticals positions in Q4 2015 and 1 closed out, a net change of +5 holders.
- The largest Sonoma Pharmaceuticals buyer in Q4 2015 was Bard Associates, an estimated $688K added.
- The largest Sonoma Pharmaceuticals seller in Q4 2015 was Goldman Sachs, an estimated $78.8K sold.
Based on aggregated 13F filings for Q4 2015.